Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders

The development of new treatments for substance use disorders requires identification of targetable molecular mechanisms. Pathology in glutamatergic neurotransmission system in brain reward circuitry has been implicated in relapse to multiple classes of drugs. Glutamate transporter 1 (GLT-1) crucial...

Full description

Saved in:
Bibliographic Details
Published inCNS & neurological disorders drug targets Vol. 14; no. 6; p. 745
Main Authors Roberts-Wolfe, Douglas J, Kalivas, Peter W
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2015
Subjects
Online AccessGet more information

Cover

Loading…